Industry Biotechnology
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| BOSCX | 20.10 | -0.20 | -0.99% |
| BNY Mellon Sm Cp Val C | |||
| MGTSX | 38.37 | -0.44 | -1.13% |
| Morgan Stanley Inst Global Opp R6 | |||
| BSPAX | 688.07 | -9.11 | -1.31% |
| iShares S&P 500 Index Investor A | |||
| LMISX | 25.12 | -0.38 | -1.49% |
| Franklin U.S. Large Cap Equity IS | |||
| UOPIX | 109.07 | -5.51 | -4.81% |
| ProFunds UltraNASDAQ-100 Inv | |||
A.I.dvisor tells us that ACUT and KMSTF have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ACUT and KMSTF's prices will move in lockstep.
| Ticker / NAME | Correlation To ACUT | 1D Price Change % | ||
|---|---|---|---|---|
| ACUT | 100% | N/A | ||
| KMSTF - ACUT | 28% Poorly correlated | N/A | ||
| MOLN - ACUT | 21% Poorly correlated | +1.52% | ||
| BIOR - ACUT | 20% Poorly correlated | -10.92% | ||
| PHGE - ACUT | 20% Poorly correlated | -17.33% | ||
| TELIF - ACUT | 11% Poorly correlated | -9.16% | ||
More | ||||